Results 171 to 180 of about 129,951 (312)

New Pyridobenothiazolone Derivatives Display Nanomolar Pan‐Serotype Anti‐Dengue Virus Activity

open access: yesChemMedChem, EarlyView.
A ligand‐based strategy is employed, starting from hit compound 2, to develop the C‐2 modified pyridobenzothiazolone 19 as a pan‐serotype nanomolar DENV‐1‐4 inhibitor. Investigations of the mechanism reveal the peculiar ability to abolish the infectivity of virions in a second infection.
Tommaso Felicetti   +13 more
wiley   +1 more source

Trans-thoracic microwave coagulo-necrotic therapy for hepatic tumors without chest tube insertion

open access: bronze, 2001
Yasuharu Ikeda   +8 more
openalex   +2 more sources

Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Background Febrile infection‐related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness. Patient Description We describe a 12‐year‐old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT‐DEX ...
Carol Park   +10 more
wiley   +1 more source

An alternative to chest tube thoracostomy equipment. [PDF]

open access: yesTurk Gogus Kalp Damar Cerrahisi Derg
Keskin H, Kuran E.
europepmc   +1 more source

Effectiveness of Single Chest Tube vs Double Chest Tube Application Postdecortication: Prospective Randomized Controlled Study. [PDF]

open access: yesJ Am Coll Surg, 2023
Hart JM   +7 more
europepmc   +1 more source

Improved drainage with active chest tube clearance☆☆☆ [PDF]

open access: bronze, 2010
Akira Shiose   +7 more
openalex   +1 more source

Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1393-1402, May 2025.
Ritonavir‐boosted atazanavir is a victim of drug–drug interaction with rifampicin, a key component of antitubercular treatment. In a recent dose escalation clinical trial, we showed that increasing atazanavir/ritonavir to 300/100 mg b.i.d. compensates for reduced drug exposure in plasma due to rifampicin, but the intracellular effects remained ...
Amedeo De Nicolò   +16 more
wiley   +1 more source

Comparative Analysis of Analog and Digital Chest Tube Drainage Systems Using a High-Fidelity 3D-Printed Neonatal Chest Model. [PDF]

open access: yesPediatr Pulmonol
Anzinger FX   +6 more
europepmc   +1 more source

Chest Tube Placement and Management: A Practical Review. [PDF]

open access: yesSemin Intervent Radiol, 2023
Roebker JA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy